OA10242A - Sels de céphème cristallins d'addition avec des acides procédés pour leur préparation médicaments les contenant et leur utilisation - Google Patents

Sels de céphème cristallins d'addition avec des acides procédés pour leur préparation médicaments les contenant et leur utilisation Download PDF

Info

Publication number
OA10242A
OA10242A OA60734A OA60734A OA10242A OA 10242 A OA10242 A OA 10242A OA 60734 A OA60734 A OA 60734A OA 60734 A OA60734 A OA 60734A OA 10242 A OA10242 A OA 10242A
Authority
OA
OAPI
Prior art keywords
acides
acide
formule
que
acid
Prior art date
Application number
OA60734A
Other languages
English (en)
French (fr)
Inventor
Rudolf Dr Lattrell
Walter Dr Duerckheimer
Peter Dr Schmid
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA10242A publication Critical patent/OA10242A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA60734A 1994-11-10 1995-11-10 Sels de céphème cristallins d'addition avec des acides procédés pour leur préparation médicaments les contenant et leur utilisation OA10242A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
OA10242A true OA10242A (fr) 1997-09-19

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60734A OA10242A (fr) 1994-11-10 1995-11-10 Sels de céphème cristallins d'addition avec des acides procédés pour leur préparation médicaments les contenant et leur utilisation

Country Status (28)

Country Link
US (1) US5747484A (ko)
EP (1) EP0711774B1 (ko)
JP (1) JP3920939B2 (ko)
KR (1) KR100449191B1 (ko)
CN (1) CN1066452C (ko)
AR (1) AR002246A1 (ko)
AT (1) ATE213248T1 (ko)
AU (1) AU707730B2 (ko)
BR (1) BR9505132A (ko)
CA (1) CA2162530C (ko)
CZ (1) CZ290936B6 (ko)
DE (2) DE4440141A1 (ko)
DK (1) DK0711774T3 (ko)
ES (1) ES2172549T3 (ko)
FI (1) FI120263B (ko)
HU (1) HU219475B (ko)
IL (1) IL115914A (ko)
MA (1) MA23709A1 (ko)
NO (1) NO311891B1 (ko)
NZ (1) NZ280424A (ko)
OA (1) OA10242A (ko)
PL (1) PL182806B1 (ko)
PT (1) PT711774E (ko)
RU (1) RU2161619C2 (ko)
SK (1) SK282545B6 (ko)
TR (1) TR199501392A2 (ko)
TW (1) TW422847B (ko)
ZA (1) ZA959510B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049130A2 (en) * 1997-04-29 1998-11-05 The University Of New Mexico Hydroxynaphthoic acids and derivatives
ATE327759T1 (de) * 2002-10-25 2006-06-15 Akzo Nobel Nv Pharmazeutische zusammensetzung mit verlungerter freisetzung
EP1945223B1 (en) * 2005-10-29 2010-07-07 Intervet International BV Cefquinome compositions and methods of their use
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
WO2013049294A1 (en) * 2011-09-29 2013-04-04 Alere San Diego, Inc. 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274990A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2015012833A (es) 2013-03-15 2016-06-10 Merck Sharp & Dohme Composiciones antibioticas de ceftolozano.
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
TR199501392A2 (tr) 1996-07-21
KR960017670A (ko) 1996-06-17
ATE213248T1 (de) 2002-02-15
JP3920939B2 (ja) 2007-05-30
PL182806B1 (pl) 2002-03-29
CZ293395A3 (en) 1996-05-15
FI955382A0 (fi) 1995-11-08
NO311891B1 (no) 2002-02-11
CN1129220A (zh) 1996-08-21
EP0711774B1 (de) 2002-02-13
BR9505132A (pt) 1997-09-09
PT711774E (pt) 2002-07-31
HUT74163A (en) 1996-11-28
DE59510048D1 (de) 2002-03-21
DK0711774T3 (da) 2002-04-22
DE4440141A1 (de) 1996-05-15
EP0711774A1 (de) 1996-05-15
NO954511L (no) 1996-05-13
NO954511D0 (no) 1995-11-09
SK139795A3 (en) 1996-06-05
HU219475B (hu) 2001-04-28
IL115914A (en) 2002-08-14
CA2162530C (en) 2007-07-31
CA2162530A1 (en) 1996-05-11
ES2172549T3 (es) 2002-10-01
RU2161619C2 (ru) 2001-01-10
ZA959510B (en) 1996-05-28
AU707730B2 (en) 1999-07-15
AR002246A1 (es) 1998-03-11
HU9503213D0 (en) 1996-01-29
CN1066452C (zh) 2001-05-30
KR100449191B1 (ko) 2006-01-12
FI120263B (fi) 2009-08-31
US5747484A (en) 1998-05-05
SK282545B6 (sk) 2002-10-08
PL311326A1 (en) 1996-05-13
AU3772895A (en) 1996-05-16
FI955382A (fi) 1996-05-11
IL115914A0 (en) 1996-01-31
JPH08208662A (ja) 1996-08-13
NZ280424A (en) 1997-06-24
CZ290936B6 (cs) 2002-11-13
MA23709A1 (fr) 1996-07-01
TW422847B (en) 2001-02-21

Similar Documents

Publication Publication Date Title
EP0606024B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
OA10242A (fr) Sels de céphème cristallins d'addition avec des acides procédés pour leur préparation médicaments les contenant et leur utilisation
FR2555584A1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
FR2464956A1 (fr) Procede de production de 10-deazaminopterine et de ses derives 10-alkyliques, composes obtenus et composition pharmaceutique les contenant
SU805948A3 (ru) Способ получени -аминофосфонистыхКиСлОТ
FR2466469A1 (fr) Bischlorhydrate de cephalosporine, son procede de preparation et ses applications, notamment en therapeutique
FR2500833A1 (fr) Nouveaux derives de l'acide (pyrrolidinyl-1)-7 fluoro-6 dihydro-1,4 oxo-4 naphtyridine-1, 8 carboxylique-3 et leur utilisation comme medicament
CH621125A5 (ko)
EP0043756B1 (fr) 1,2,4-Triazinylthiométhyl-3-céphèmes sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant
US4439436A (en) 1,3-Dioxolo(4,5-G)quinoline compounds
EP0136198B1 (fr) Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques
FR2502152A1 (fr) Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant
EP0946579A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2756825A1 (fr) Nouveaux derives [3h]-benzoxazole-2-thiones et [3h]- benzothiazole-2-thiones substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2612185A1 (fr) Derives oxo-isoindolinyliques optiquement actifs, leur preparation et leur utilisation comme medicaments
US4439363A (en) Acetylmethyl ester of hetacyllin and/or salts of this ester
US4035381A (en) Antibacterial agents
FR2485540A1 (fr) Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant
EP0395526A1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2651129A1 (fr) Nouveaux derives de cysteine; compositions pharmaceutiques ou cosmetiques en contenant.
BE876466A (fr) Derive de l'acide penicillanique et son procede de preparation
US3794678A (en) (1,4-cyclohexadien-1-yl)acetic acid
LU83775A1 (fr) Derives de naphtyridine,leur preparation et leur application en therapeutique
FR2621589A1 (fr) Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2491927A1 (fr) Derives de cephalexine solubles dans l'eau, et procede pour leur preparation